Clinical and Applied Thrombosis/Hemostasis (May 2022)

Association Between Monocyte Count and Preoperative Deep Venous Thrombosis in Older Patients with hip Fracture: A Retrospective Study

  • Zhicong Wang,
  • Qing Zhou,
  • Hailong Liu,
  • Jianjun Zhang,
  • Zhonglun Zhu,
  • Jijun Wu,
  • Xue Chen,
  • Yuehong Liu

DOI
https://doi.org/10.1177/10760296221100806
Journal volume & issue
Vol. 28

Abstract

Read online

Purpose To analyze the relationship between monocyte count and preoperative deep venous thrombosis (DVT) in older patients with hip fracture. Methods Consecutive older patients with hip fracture undergoing surgery were included from January 2014 to December 2021. Monocyte count was measured on admission, and Doppler ultrasonography was performed for DVT screening prior to surgery. Univariate and multivariate logistic regression analyses were used to assess the association between monocyte count and DVT. Results A total of 674 patients were finally included, and 128 patients (19.0%) were diagnosed with preoperative DVT. Patients with DVT exhibited a higher monocyte count than patients without DVT [0.55 (0.43-0.72) × 10 9 /L versus 0.49 (0.38-0.63) × 10 9 /L, P = 0.007]. Multivariate logistic regression analysis showed that a high monocyte count (> 0.6 × 10 9 /L) was independently associated with a higher risk of DVT (OR = 1.705, 95% CI : 1.121-2.593, P = 0.013), and for every 0.1 × 10 9 /L increase in monocyte count, the risk of DVT increased by 8.5% (OR = 1.085, 95% CI : 1.003-1.174, P = 0.041). Other risk factors associated with DVT included intertrochanteric fracture (OR = 1.596, 95% CI : 1.022-2.492, P = 0.040), and elevated fibrinogen level (OR = 1.236, 95% CI : 1.029-1.484, P = 0.023). Conclusion A high monocyte count is associated with an increased risk of DVT in older patients with hip fracture. Future studies should evaluate the potential role of monocyte in the prevention and treatment of thrombosis.